Zheng Quan Shi Bao·2026-01-21 17:35Group 1 - The core viewpoint of the news is that several A-share companies have announced significant growth in their 2025 performance forecasts, with notable increases in net profits for companies like Jin'an Guoji and Limin Co. [1][2] - Jin'an Guoji expects a net profit of 280 million to 360 million yuan for 2025, representing a year-on-year increase of 655.53% to 871.4% [1] - The growth in Jin'an Guoji's performance is attributed to the recovery of the copper-clad laminate market, increased production and sales volume, and improved sales prices [1] - Limin Co. forecasts a net profit of 465 million to 500 million yuan for 2025, with a year-on-year growth of 471.55% to 514.57% [1] - The increase in Limin Co.'s net profit is driven by higher sales and prices of its main products, improved gross margins, and increased investment income from its subsidiaries [1] Group 2 - Juhua Co. anticipates a net profit of 3.54 billion to 3.94 billion yuan for 2025, reflecting a year-on-year growth of 80% to 101% [2] - The significant profit increase for Juhua Co. is mainly due to the continuous recovery in prices of its core product, fluorinated refrigerants, and stable production and sales volumes [2] - Shanghai Yizhong expects a net profit of 6 million to 7 million yuan for 2025, with a year-on-year increase of 760.18% to 903.54% [2] - The growth for Shanghai Yizhong is linked to the inclusion of its core product, injectable paclitaxel polymer micelles, in the national medical insurance directory, which significantly boosts market access and patient numbers [2] - Shanghai Yizhong focuses on the development of innovative anti-tumor drugs and has a complete drug research and production system [2]